Skip to content

MESO

Mesoblast Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$15.67
+17.03%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
117.77x
P/S forward
131.18x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.59x
Price / sales
16.88x
Price / cash flow
-49.34x

Enterprise value

Enterprise value
$2.1B
EV / sales
17.08x
EV / EBITDA
-47.18x
EV / EBIT
-17.47x
Market cap
$2.0B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026